DEXMETHYLPHENIDATE HYDROCHLORIDE | A078992 | PLATINUM PHARMACEUTICALS
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition Amendment from Senores Pharmaceuticals, Inc. FDA-2026-P-7183 · 8 docket documents Senores Pharmaceuticals, Inc. filed an amendment to a prior suitability petition requesting that the FDA determine whether a manufacturing process for a drug substance is suitable for use in an abbreviated new drug application. The amendment updates information previously submitted regarding the pro | Suitability | 2026-07-21 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$1.76
per ea
Lowest NADAC/Unit
$0.8329
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 49884043001DEXMETHYLPHENIDATE ER 30 MG CP | $1.76 | EA | Generic | — | 2026-08-19 |
| 49884042801DEXMETHYLPHENIDATE ER 15 MG CP | $0.8329 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.